Black Diamond Therapeutics Inc (BDTX)
2.54
+0.11
(+4.53%)
USD |
NASDAQ |
Nov 22, 16:00
2.55
+0.01
(+0.39%)
After-Hours: 20:00
Black Diamond Therapeutics Cash from Operations (Quarterly): -11.32M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.32M |
| June 30, 2024 | -14.73M |
| March 31, 2024 | -21.20M |
| December 31, 2023 | -13.96M |
| September 30, 2023 | -18.36M |
| June 30, 2023 | -14.37M |
| March 31, 2023 | -20.03M |
| December 31, 2022 | -21.94M |
| September 30, 2022 | -16.48M |
| June 30, 2022 | -18.07M |
| March 31, 2022 | -28.60M |
| December 31, 2021 | -24.05M |
| Date | Value |
|---|---|
| September 30, 2021 | -26.48M |
| June 30, 2021 | -25.16M |
| March 31, 2021 | -24.46M |
| December 31, 2020 | -15.77M |
| September 30, 2020 | -11.49M |
| June 30, 2020 | -13.57M |
| March 31, 2020 | -11.32M |
| December 31, 2019 | -7.486M |
| September 30, 2019 | -5.31M |
| June 30, 2019 | -5.00M |
| March 31, 2019 | -6.878M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-28.60M
Minimum
Mar 2022
-7.486M
Maximum
Dec 2019
-17.94M
Average
-17.27M
Median
Cash from Operations (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -14.58M |
| IDEAYA Biosciences Inc | -49.23M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
| iBio Inc | -3.715M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.193M |
| Cash from Financing (Quarterly) | -0.252M |
| Free Cash Flow | -61.20M |
| Free Cash Flow Per Share (Quarterly) | -0.2004 |
| Free Cash Flow Yield | -44.79% |